# Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

> **NCT00571155** · PHASE4 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 30 (estimated)

## Conditions studied

- Primary Brain Tumor
- Epilepsy

## Interventions

- **DRUG:** levetiracetam

## Key facts

- **NCT ID:** NCT00571155
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571155, "Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00571155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*